Bosh sahifaEVGN • TLV
add
Evogene Ltd
Yopilish kursi
468,50 ILA
Kunlik diapazon
449,80 ILA - 464,50 ILA
Yillik diapazon
357,30 ILA - 2 470,00 ILA
Bozor kapitalizatsiyasi
11,68 mln USD
Oʻrtacha hajm
140,33 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,44 mln | -41,67% |
Joriy xarajat | 4,96 mln | -33,45% |
Sof foyda | -2,59 mln | 33,03% |
Sof foyda marjasi | -105,85 | -14,80% |
Har bir ulushga tushum | -0,38 | 52,50% |
EBITDA | -3,55 mln | -22,48% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 9,85 mln | -62,99% |
Jami aktivlari | 34,30 mln | -26,67% |
Jami passivlari | 21,91 mln | 2,39% |
Umumiy kapital | 12,40 mln | — |
Tarqatilgan aksiyalar | 6,67 mln | — |
Narxi/balansdagi bahosi | -8,52 | — |
Aktivlardan daromad | -27,82% | — |
Kapitaldan daromad | -63,81% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -2,59 mln | 33,03% |
Operatsiyalardan naqd pul | -5,18 mln | -26,08% |
Sarmoyadan naqd pul | -2,45 mln | 43,92% |
Moliyadan naqd pul | -159,00 ming | 56,68% |
Naqd pulning sof oʻzgarishi | -7,81 mln | 11,87% |
Boʻsh pul | -5,32 mln | -80,72% |
Haqida
Evogene is a computational biology company based in Israel, specializing in predictive biology platforms that leverage artificial intelligence and machine learning for life-science product development. Evogene's platforms focus on designing novel microbes, small molecules, and genetic elements for use in pharmaceuticals, agriculture, and related industries. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
117
